Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial
Sponsor: Yonsei University
Summary
Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single antiplatelet agent to be maintained after short-term DAPT was different. Therefore, which antiplatelet agent to be maintained after short-term DAPT needs further invstigations.
Key Details
Gender
All
Age Range
19 Years - 84 Years
Study Type
INTERVENTIONAL
Enrollment
3744
Start Date
2022-07-26
Completion Date
2028-07-10
Last Updated
2024-10-22
Healthy Volunteers
No
Conditions
Interventions
Clopidogrel monotherapy
Patients will be randomized to stop aspirin and maintain clopidogrel after short-term DAPT.
Aspirin monotherapy
Patients will be randomized to stop clopidogrel and maintain aspirin after short-term DAPT.
zotarolimus-eluting stent (Resolute Onyx ®)
zotarolimus-eluting stent (Resolute Onyx ®)
Locations (1)
Yonsei University Health System, Severance Hospital
Seoul, South Korea